Leitfaden

DSCSA communications archive

Read summaries of the letters and position papers we sent to manufacturer partners about the Drug Supply Chain Security Act (DSCSA), from 2019 to 2026. 

About this communications archive

Each summary in the archive describes our requirements on the date we sent the communication.

Please note:

  • Many of those dates and requirements no longer apply.
  • Communications sent before September 2023 went out under our former name, AmerisourceBergen.

For the requirements in effect today, visit our main page for manufacturer partners.

Communications, newest first

Since November 27, 2025, most dispensers need DSCSA data for drop shipments. The letter described the 2 ways manufacturers provide this data: through the distributor, which passes the Electronic Product Code Information Services (EPCIS) data to the dispenser, or through a manufacturer portal.

It noted that many dispensers did not receive the data with drop-ship deliveries, which caused delays and refused deliveries. It asked every manufacturer to send drop-ship EPCIS files to Cencora for all drop-ship orders received through Cencora, and to send portal access instructions if it used a portal only. 

It also confirmed that Cencora sends ship-to Global Location Numbers (GLNs) and customer order numbers in drop-ship purchase orders, and it listed the DSCSA mailboxes by purpose. 

Status: Current. See our DSCSA support for manufacturers page for the rules in effect today.

With the exemption period over, missing or incomplete data could lead to quarantined product or refused shipments. The notice asked manufacturers to staff DSCSA exception handling during and after scheduled deliveries through the holidays. 

It listed the days our distribution network closed for the 2025 season: November 27, 2025, December 25, 2025, and January 1, 2026. It also listed the DSCSA mailboxes by purpose. 

Status: Current for staffing. Our DSCSA support for manufacturers page lists the closure dates for the current season.

This letter announced that our enhanced DSCSA requirements took full effect on August 27, 2025. It set our expectations for inbound deliveries: complete EPCIS data, with current master data and correct syntax, before the product arrives. 

Without that data, we hold trucks at the National Distribution Center and quarantine product at forward distribution centers, with up to 3 business days to resolve the exception before a return at the manufacturer's expense. The letter also asked manufacturers to request their own waiver, exception, or exemption (WEE) for barcodes we could not scan. 

It explained how we would ship inventory received before the requirements began, and how customer returns work for invoices before and after August 27, 2025. 

Status: Current. See our DSCSA support for manufacturers page for the rules in effect today.

This letter shared the U.S. Food and Drug Administration (FDA) dates that ended the exemption period by trading partner type: manufacturers and repackagers on May 27, 2025; wholesale distributors on August 27, 2025; and dispensers on November 27, 2025, with small dispensers following on November 27, 2026. 

It set our milestones: automated exception notifications for all suppliers from May 26, 2025, quarantine procedures from August 1, 2025, and saleable returns verified against our own serialization data from August 25, 2025. 

It asked manufacturers to staff DSCSA support during National Distribution Center delivery hours, to request a WEE by May 23, 2025, for any product that might not comply, and to send us a copy of each WEE with the affected National Drug Codes (NDCs) and the duration. 

Status: Historical for dates. The WEE rules still apply; see our DSCSA support for manufacturers page.

After the FDA announced exemptions for eligible trading partners, this letter explained that we would not quarantine product from suppliers that had set up data exchange and started sending EPCIS files, until a later date. 

It listed 4 exception types for automated notifications from January 6, 2025: EPCIS master data failures, EPCIS file failures, product with no data at receiving and picking, and trucks with no data before receiving. It set May 5, 2025, as the start of quarantine and asked for WEE requests by May 1, 2025. 

Status: Historical. The letter of May 14, 2025, replaced these dates.

This letter set out our position as the FDA stabilization period for the enhanced drug distribution security requirements came to an end. 

Status: Historical. Later communications replaced the dates and requirements in this entry.

After the FDA announced a 1-year stabilization period on August 30, 2023, this letter asked manufacturers to keep working toward the requirements due on November 27, 2023, and not to treat the period as a pause. 

It set milestones for full-line distribution, American Health Packaging, and other Cencora businesses: systems and processes ready by October 31, 2023; data exchange for aggregated products by November 27, 2023; and serialized data for every sale by March 31, 2024. 

It also explained the name change: our GLNs did not change, and GS1 updated the company name on our prefix only.

Status: Historical. Later communications replaced the dates and requirements in this entry.

This FAQ answered manufacturer questions before the November 2023 requirements. It described 3 types of barcode issues: incorrect GS1 encoding, barcodes below GS1 recommendations, and faded or degraded barcodes. 

It explained that a manufacturer that could not meet a requirement needed a WEE from the FDA, and that we needed the WEE 72 hours before shipment. It described how we would handle deliveries without data at the National Distribution Center and at forward distribution centers. 

It also explained that DSCSA data quality, case sizes, and serialized inner packs would factor into our manufacturer scorecards. 

Status: Historical. Later communications replaced the dates and requirements in this entry.

After the FDA extended enforcement discretion for the verification of saleable returns to November 27, 2023, this letter explained that we would keep sending a limited number of verification requests to find and fix barcode and data issues early. 

It asked manufacturers that did not yet send EPCIS data to start by January 1, 2023, at the latest, so we would have at least 1 year of data before the requirements took effect. 

Status: Historical. Later communications replaced the dates and requirements in this entry.

This letter reviewed the requirement, in effect since November 27, 2018, to serialize prescription products at the saleable unit and homogenous case. It explained that we would scan 2D barcodes to verify saleable returns, and that product we could not scan might go into quarantine. 

It asked manufacturers to support automated verification of saleable returns, either by sending serialized EPCIS data with each shipment or by connecting to a verification router service. 

Status: Historical. Later communications replaced the dates and requirements in this entry.